Michael Nofi

Insider Reports History

Location
100 Washington Blvd, Stamford, CT
Signature
/s/ John R. Moore, Attorney-in-Fact for Michael Nofi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Nofi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Chief Accounting Officer Common Stock 0 $0 $46.20 Jul 1, 2025 Direct
Edgewise Therapeutics, Inc. Chief Financial Officer Stock Options (Right to buy) 263K Nov 10, 2025 Direct
Edgewise Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 43.8K Nov 10, 2025 Direct
SpringWorks Therapeutics, Inc. Chief Accounting Officer Performance Share Units 0 Jul 1, 2025 Direct
SpringWorks Therapeutics, Inc. Chief Accounting Officer Stock Option (Right to Buy) 0 Jul 1, 2025 Direct

Insider Reports Filed by Michael Nofi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EWTX Edgewise Therapeutics, Inc. Nov 10, 2025 2 $0 4 Nov 13, 2025 Chief Financial Officer
EWTX Edgewise Therapeutics, Inc. Nov 10, 2025 0 $0 3 Nov 13, 2025 Chief Financial Officer
SWTX SpringWorks Therapeutics, Inc. Jul 1, 2025 6 $0 4 Jul 2, 2025 Chief Accounting Officer
SWTX SpringWorks Therapeutics, Inc. Jan 10, 2025 2 $0 4 Jan 14, 2025 Chief Accounting Officer
SWTX SpringWorks Therapeutics, Inc. Jan 4, 2025 3 -$193K 4 Jan 7, 2025 Chief Accounting Officer
SWTX SpringWorks Therapeutics, Inc. Jan 4, 2024 4 -$88.5K 4 Jan 8, 2024 Chief Accounting Officer
SWTX SpringWorks Therapeutics, Inc. Jan 7, 2023 1 -$10.8K 4 Jan 10, 2023 Chief Accounting Officer
SWTX SpringWorks Therapeutics, Inc. Jan 5, 2023 4 -$21.5K 4 Jan 9, 2023 Chief Accounting Officer
SWTX SpringWorks Therapeutics, Inc. Jan 7, 2022 1 -$23.2K 4/A Jan 14, 2022 Chief Accounting Officer
SWTX SpringWorks Therapeutics, Inc. Jan 6, 2022 2 $0 4 Jan 10, 2022 Chief Accounting Officer